Fachrepositorium Lebenswissenschaften

19 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results

Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas

2020 . Arolt, Christoph | Meyer, Moritz | Ruesseler, Vanessa | Nachtsheim, Lisa | Wuerdemann, Nora | Dreyer, Thomas | Gattenlöhner, Stefan | Wittekindt, Claus | Buettner, Reinhard | Quaas, Alexander | Klussmann, Jens Peter

EGFR and BRAF mutations in inverted sinonasal papilloma — a more complex landscape?

2020 . Zonnur, Sarah | Erbersdobler, Andreas | Schneider, Bjoern

Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia

Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation

2020 . Hinze, Anna | Rinke, Jenny | Hochhaus, Andreas | Ernst, Thomas

Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma

2020 . Saeed, Mohamed E. M. | Kadioglu, Onat | Greten, Henry Johannes | Yildirim, Adem | Mayr, Katharina | Wenz, Frederik | Giordano, Frank A. | Efferth, Thomas

Comparative genomic profiling of glandular bladder tumours

The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations

2020 . Willvonseder, Barbara | Stögbauer, Fabian | Steiger, Katja | Jesinghaus, Moritz | Kuhn, Peer-Hendrik | Brambs, Christine | Engel, Jutta | Bronger, Holger | Schmidt, Georg Philipp | Haller, Bernhard | Weichert, Wilko | Keller, Gisela | Noske, Aurelia | Pfarr, Nicole | Boxberg, Melanie

Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer

2020 . Michl, M. | Taverna, F. | Kumbrink, J. | Schiergens, T. S. | Heinemann, V. | Engel, J. | Kirchner, T. | Neumann, Jens

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

Seiten